Comparison of non-invasive scores for the evaluation of liver fibrosis in subjects with metabolic dysfunction-associated fatty liver disease (MAFLD)
Introduction and Objectives: Metabolic-associated fatty liver disease (MAFLD) poses a significant risk for progression to advanced liver diseases, underscoring the need for early detection. This study aims to assess and compare the diagnostic efficacy of non-invasive markers (APRI, FIB-4, Hepamet, a...
Main Authors: | Bryan A. Priego-Parra, Arturo Triana-Romero, Raúl Bernal-Reyes, María E. Icaza-Chávez, Sophia E. Martínez-Vázquez, Ana D. Cano-Contreras, Héctor Vivanco-Cid, José M. Remes-Troche |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | Annals of Hepatology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268124002461 |
Similar Items
-
Hepatic Steatosis Index (HSI): A Valuable Biomarker in Subjects with Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
by: Bryan A. Priego-Parra, et al.
Published: (2024-02-01) -
Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies
by: Qingfu Dong, et al.
Published: (2023-04-01) -
Mediterranean diet vs. regional diet in a Mexican population with MAFLD: 3-month cohort
by: MJJ García-Carvajal, et al.
Published: (2022-12-01) -
Changes in physical activity and its impact on MAFLD during the COVID-19 pandemic
by: MJJ García-Carvajal, et al.
Published: (2022-12-01) -
Prevalence and clinical-epidemiologic characteristics of a Mexican population with metabolic (dysfunction) associated fatty liver disease: An open population study
by: R. Bernal-Reyes, et al.
Published: (2023-07-01)